Literature DB >> 3964685

Halo enol lactones: studies on the mechanism of inactivation of alpha-chymotrypsin.

S B Daniels, J A Katzenellenbogen.   

Abstract

In a previous investigation [Daniels, S. B., Cooney, E., Sofia, M. J., Chakravarty, P. K., & Katzenellenbogen, J. A. (1983) J. Biol. Chem. 258, 15046-15053], we demonstrated that alpha-aryl-substituted five- and six-membered ring halo enol lactones were effective inhibitors of chymotrypsin, and we proposed that they reacted by an enzyme-activated mechanism: acyl transfer to the active site serine generates a halomethyl ketone that remains tethered in the catalytic site until it alkylates an accessible nucleophilic residue. In this study, we have investigated in greater detail the process of chymotrypsin inactivation by an alpha-naphthyl-substituted five- and six-membered bromo enol lactone. Inactivation by both compounds appears to be active site directed, since the time-dependent inactivation is retarded by competing substrate. The possible involvement of a paracatalytic mechanism for inactivation (generation of a free, rather than active site bound, inactivating species) was investigated by comparing the inactivation efficiencies of the lactones with that of the bromomethyl keto acid hydrolysis products. The bromomethyl ketone derived from the five-membered lactone is ineffective, whereas that derived from the six-membered lactone is highly efficient. However, the possible involvement of the free keto acid in chymotrypsin inactivation by the six-membered lactone is ruled out by experiments involving selective scavenging. The long-term inactivation of chymotrypsin requires the presence of the bromine substituent and appears to involve an alkylation rather than an acylation reaction (hydrazine resistant). Furthermore, a 1:1 lactone:enzyme stoichiometry is demonstrated with the 14C-labeled six-membered lactone. These results are consistent with the mechanism-based inactivation process previously presented.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3964685     DOI: 10.1021/bi00354a037

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  A bromoenol lactone suicide substrate inactivates group VIA phospholipase A2 by generating a diffusible bromomethyl keto acid that alkylates cysteine thiols.

Authors:  Haowei Song; Sasanka Ramanadham; Shunzhong Bao; Fong-Fu Hsu; John Turk
Journal:  Biochemistry       Date:  2006-01-24       Impact factor: 3.162

2.  Combination therapy of an inhibitor of group VIA phospholipase A2 with paclitaxel is highly effective in blocking ovarian cancer development.

Authors:  Hui Li; Zhenwen Zhao; Caryl Antalis; Zhanzhong Zhao; Robert Emerson; Gang Wei; Sheng Zhang; Zhong-Yin Zhang; Yan Xu
Journal:  Am J Pathol       Date:  2011-05-17       Impact factor: 4.307

3.  Haloenol lactones as inactivators and substrates of aldehyde dehydrogenase.

Authors:  N Mukerjee; M Dryjanski; W Dai; J A Katzenellenbogen; R Pietruszko
Journal:  J Protein Chem       Date:  1996-10

4.  Insulin resistance in HIV protease inhibitor-associated diabetes.

Authors:  K E Yarasheski; P Tebas; C Sigmund; S Dagogo-Jack; A Bohrer; J Turk; P A Halban; P E Cryer; W G Powderly
Journal:  J Acquir Immune Defic Syndr       Date:  1999-07-01       Impact factor: 3.731

5.  Effects of biological oxidants on the catalytic activity and structure of group VIA phospholipase A2.

Authors:  Haowei Song; Shunzhong Bao; Sasanka Ramanadham; John Turk
Journal:  Biochemistry       Date:  2006-05-23       Impact factor: 3.162

6.  Haloenol pyranones and morpholinones as antineoplastic agents of prostate cancer.

Authors:  Jason N Mock; John P Taliaferro; Xiao Lu; Sravan Kumar Patel; Brian S Cummings; Timothy E Long
Journal:  Bioorg Med Chem Lett       Date:  2012-05-17       Impact factor: 2.823

7.  Mechanism-based inhibition of iPLA2β demonstrates a highly reactive cysteine residue (C651) that interacts with the active site: mass spectrometric elucidation of the mechanisms underlying inhibition.

Authors:  Christopher M Jenkins; Jingyue Yang; Richard W Gross
Journal:  Biochemistry       Date:  2013-06-10       Impact factor: 3.162

8.  Inhibition of pancreatic cholesterol esterase reduces cholesterol absorption in the hamster.

Authors:  John E Heidrich; Linda M Contos; Lucy A Hunsaker; Lorraine M Deck; David L Vander Jagt
Journal:  BMC Pharmacol       Date:  2004-04-19

9.  Characterization of FKGK18 as inhibitor of group VIA Ca2+-independent phospholipase A2 (iPLA2β): candidate drug for preventing beta-cell apoptosis and diabetes.

Authors:  Tomader Ali; George Kokotos; Victoria Magrioti; Robert N Bone; James A Mobley; William Hancock; Sasanka Ramanadham
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.